Macquarie Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.52M | Hold |
|
|||||
|
2023
Q3 | $2.61M | Hold |
|
|||||
|
2023
Q2 | $2.17M | Hold |
|
|||||
|
2023
Q1 | $2.23M | Hold |
|
|||||
|
2022
Q4 | $2.72M | Sell |
|
|||||
|
2022
Q3 | $4.26M | Sell |
|
|||||
|
2022
Q2 | $4.1M | Sell |
|
|||||
|
2022
Q1 | $5.76K | Buy |
|
|||||
|
2021
Q4 | $10.2M | Buy |
|
|||||
|
2021
Q3 | $12.3M | Sell |
|
|||||
|
2021
Q2 | $11.7M | Sell |
|
|||||
|
2021
Q1 | $14M | Sell |
|
|||||
|
2020
Q4 | $20.6M | Sell |
|
|||||
|
2020
Q3 | $19.9M | Sell |
|
|||||
|
2020
Q2 | $21.1M | Buy |
|
|||||
|
2020
Q1 | $13.7M | Hold |
|
|||||
|
2019
Q4 | $23M | Sell |
|
|||||
|
2019
Q3 | $18.4M | Buy |
|
|||||
|
2019
Q2 | $23M | Hold |
|
|||||
|
2019
Q1 | $16.4M | Hold |
|
|||||
|
2018
Q4 | $9.49M | Hold |
|
|||||
|
2018
Q3 | $10.5M | Sell |
|
|||||
|
2018
Q2 | $11.1M | Buy |
|
|||||
|
2018
Q1 | $6.87M | Buy |
|
|||||
|
2017
Q4 | $1.47M | Buy |
|
|||||
|
2017
Q3 | $936K | Hold |
|
|||||
|
2017
Q2 | $292K | Hold |
|
|||||
|
2017
Q1 | $416K | Hold |
|
|||||
|
2016
Q4 | $380K | Hold |
|
|||||
|
2016
Q3 | $529K | Sell |
|
|||||
|
2016
Q2 | $874K | Buy |
|